Gene · 4607
NIH grants2,246
NIH grants whose papers are about the gene, through NIH's grant-paper links.
701 to 720 of 2,246
Download this page as JSON| Grant | Title | MYBPC3 papers | Newest fiscal year |
|---|---|---|---|
| U01AG046139 | A Systems Approach to Targeting Innate Immunity in AD | 1 | 2022 |
| U01AG046170 | Integrative Network Biology Approaches to Identify, Characterize and Validate Molecular Subtypes in Alzheimer's Disease | 1 | 2022 |
| U01AI142756 | Expanding the Scope of Base Editing | 1 | 2022 |
| U01HG007672 | An integrated and diverse genomic medicine program for undiagnosed diseases | 1 | 2022 |
| U01HL156349 | Human cardiac microtissues with innate immune sensing to study adverse consequences of genome editing | 1 | 2022 |
| U24DC015910 | The Human Temporal Bone Laboratory Resource for Basic and Applied Inner Ear Sciences | 1 | 2022 |
| UH3TR002636 | Efficient in Vivo RNP-based Gene Editing in the Sensory Organ Inner Ear Using Bioreducible Lipid Nanoparticles | 1 | 2022 |
| UL1TR002240 | Michigan Institute for Clinical and Health Research (MICHR) | 1 | 2022 |
| UL1TR002494 | University of Minnesota Clinical and TranslationalmScience Institute (UMN CTSI) | 1 | 2022 |
| ZIAHL006201 | Inflammatory and immune dysregulation associated lung disease | 1 | 2022 |
| ZICHL005903 | Proteomics Core | 1 | 2022 |
| R01HL117138 | Molecular characterization of cardiomyopathy mutations in human cardiac myosin | 14 | 2021 |
| R01HL139883 | Mechanism of regulation of cardiac contraction by phosphorylation of myosin binding protein C | 12 | 2021 |
| R01HL114940 | Integrated Crosstalk of Thin Filament Post-translational Modifications | 10 | 2021 |
| T32GM007753 | Medical Scientist Training Program | 8 | 2021 |
| K08HL136839 | The Role of Junctophilin Type 2 in Cardiac Node Automaticity | 7 | 2021 |
| R01HL096971 | Top-Down Proteomics of Myofilaments in Heart Failure | 7 | 2021 |
| R01HL123968 | Modeling Susceptibility to Chemotherapy-Induced Cardiotoxicity Using Human iPSCs | 6 | 2021 |
| U01HL133359 | Multiscale modeling of inherited cardiomyopathies and therapeutic interventions | 6 | 2021 |
| R01GM125085 | MASH Explorer, a Comprehensive Software Environment for Top-Down Proteomics | 5 | 2021 |
Source NIH's project filesgene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4607/grants?page=36